HIV experts from Emory and beyond will explore "The End of AIDS? The Future of Cure and the Current Reality of HIV in Vulnerable Populations" at the 2015 Center for AIDS Research at Emory Science Symposium, set for Thursday, March 19.
Registration is not required for the symposium, which takes place from 9:30 a.m. to 4:30 p.m. in the Lawrence P. & Ann Estes Klamon Room on the eighth floor of the Claudia Nance Rollins Building of Rollins School of Public Health.
The day is structured around three sessions focusing on three key areas of HIV research: cure, HIV and women, and HIV and men who have sex with men (MSM). Each session will feature an external expert followed by two experts from Emory.
The day ends with a closing plenary featuring Michael S. Saag of the University of Alabama - Birmingham speaking on "Ending AIDS: How Do We Get There from Here?"
Speakers for the three sessions include:
Session 1: HIV Cure
- "Towards HIV Eradication: Understanding Latency Reversal and Reservoir Clearance," David Margolis, University of North Carolina at Chapel Hill
- "TG A5336: A Randomized, Pilot Study of Ruxolitinib Antiretroviral-Treated HIV-Infected Adults," Vince Marconi, Emory School of Medicine
- "Adaptations at the Maternal-Fetal Interface Prevent in Utero HIV-1 Transmission," Rana Chakraborty, Emory University School of Medicine
Session 2: HIV and Women
- "Vaccination Prevention of HIV Entry into the Mucosa," Julie McElrath, Fred Hutchinson Cancer Research Center, University of Washington
- "Promoting Team Science in HIV/AIDS & Women's Health," Igho Ofotokun, Emory School of Medicine
- "Novel Multidimensional Strategies to Address Women's HIV Vulnerability: Insights From HPTN 064, Project LINK and WIHS Studies," Paula Frew, Emory University School of Medicine
Session 3: HIV and MSM
- "Antiretrovirals and HIV Prevention in MSM: Silver Bullets or Bright Shiny Objects?" Kenneth Mayer, T.H. Chan School of Public Health, Harvard University
- "Understanding Rectal HIV Transmission," Colleen Kelley, Emory School of Medicine
- "The Hurdle of Prevalence and How Biomedical Prevention Can Reduce HIV Disparities Among MSM," Eli Rosenberg, Rollins School of Public Health, Emory University